Proteoglycans in Lung Disease

<p>Discusses new treatment strategies for malignant mesothelioma pulmonary edema fibrosis asthma emphysema and bronchiectasis.<br><br>Proteoglycans in Lung Disease considers</p><li>glycosaminoglycans as novel therapeutic agents or targets in lung disease <br> </li><li>the role of proteoglycans in determining mechanical behavior of lung tissue <br> </li><li>hyaluronan and its receptors in wound healing inflammation vasculogenesis and angiogenesis <br> </li><li>the impact of small proteoglycans on matrix assembly <br> </li><li>versican as a modulator of cell adhesion migration and proliferation <br> </li><li>antiproliferative activity of heparin and its derivatives on pulmonary artery smooth muscle cells <br> </li><li>the effects of mechanical strain on proteoglycans <br> </li><li>the functions of proteoglycans in the vascular wall <br> </li><li>the effect of hypoxia on glycosaminoglycans in the lung <br>Comprised of more than 1940 references Proteoglycans in Lung Disease</li>